Max Healthcare Institute Ltd (MAXHEALTH.NS) stock analysis

In our weekly check, Max Healthcare Institute Ltd is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2.

About Max Healthcare Institute Ltd

Max Healthcare Institute Ltd is a Healthcare company (Medical - Care Facilities) based in India, listed on NSE as MAXHEALTH.NS.

What our checks show for MAXHEALTH.NS

Red flags

• The price is 54.4 times earnings (P/E): the market already pays for a lot of future growth.
• Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.

Warning signs

• Analysts expect the net margin to shrink by 0.3 points from today's 16.7%.
• Free cash flow is only 1.7% of revenue.
• The stock is still below its previous peak.

Strengths

• Debt is low: 0x equity.
• The net margin rose by 1.4 points over 5 years, to 16.7%.
• Analysts expect earnings per share to grow about 25.8% a year over the next years.
• Analysts expect revenue to grow about 26.8% a year over the next years.
• Revenue grew 24.1% a year over the last 3 years.
• Beta 0.13: the stock usually moves less than the market.

Next earnings report: 2026-10-30

Similar companies

BDMS-R.BK · HCA · RDOR3.SA

Questions

What grade does Max Healthcare Institute Ltd (MAXHEALTH.NS) have?

In our weekly check, Max Healthcare Institute Ltd is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 3, red flags: 2. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of MAXHEALTH.NS stock?

This week's biggest flags for Max Healthcare Institute Ltd: High P/E, Low return on capital, Margins expected to shrink. In total 5 of 25 checks show a warning or a red flag.

What does Max Healthcare Institute Ltd do?

Max Healthcare Institute Ltd is a Healthcare company (Medical - Care Facilities) based in India, listed on NSE as MAXHEALTH.NS.

When does Max Healthcare Institute Ltd report earnings next?

The next earnings report is expected on 2026-10-30. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis